Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Cohort 1: JMKX003142 and itraconazole
(D00350)		[1] Itraconazole[1] Itraconazole (D00350) 💬 --[1] 67 💬
2Itraconazole
(D00350)		[1] Itraconazole[1] Itraconazole (D00350) 💬 --[13] 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
3Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.
(D00350)		[2] Itraconazole,
Terbinafine		[3] Itraconazole (D00350),
Terbinafine hydrochloride ,
Terbinafine 💬 		--[1] 96 💬
4Itraconazole 65 MG
(D00350)		[1] Itraconazole[1] Itraconazole (D00350) 💬 --[1] 299 💬
5Itraconazole/voriconazole
(D00350)		[2] Itraconazole,
Voriconazole		[2] Itraconazole (D00350),
Voriconazole 💬 		--[1] 299 💬
6Itraconazole? SHR0302 tablets
(D00350)		[1] Itraconazole[1] Itraconazole (D00350) 💬 --[1] 46 💬
7Radiprodil with Itraconazole
(D00350)		[2] Itraconazole,
Radiprodil		[2] Itraconazole (D00350),
Radiprodil 💬 		[1] GRIN2B 💬 [21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[2] 137, 158 💬